Gracell Biotechnologies Inc.: income_tax_expense
| Value | {"unit": "CNY", "value": 0, "concept": "us-gaap:IncomeTaxExpenseBenefit"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | Gracell Biotechnologies Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c6cd6c08-b748-4c4f-92cd-23b5c4352614
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-221202Retrieved: 2026-08-19T18:23:15.844735+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001826492/income-tax-expense/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c6cd6c08-b748-4c4f-92cd-23b5c4352614
History
- no predecessors — first report